(S (NP-SBJ (NP (JJ Stable) (NN expression)) (PP (IN of) (NP (JJ transdominant) (NN Rev) (NN protein))) (PP (IN in) (NP (JJ human) (NN T) (NNS cells)))) (VP (VBZ inhibits) (NP (JJ human) (NN immunodeficiency) (NN virus) (NN replication))) (. .))
(S (NP-SBJ (DT The) (NP (NP (JJ human) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN HIV)) (-RRB- -RRB-))) (NN Rev) (NN protein)) (VP (VBZ is) (ADJP-PRD (JJ essential) (PP-COOD (PP (IN for) (NP (NP (JJ viral) (JJ structural) (NN protein) (NN expression)) (PRN (-LRB- -LRB-) (NP-COOD (NP (NN Gag)) (, ,) (NP (NN Pol)) (, ,) (CC and) (NP (NN Env))) (-RRB- -RRB-)))) (CC and) (, ,) (RB hence) (, ,) (PP (IN for) (NP (JJ viral) (NN replication)))))) (. .))
(S (PP (IN In) (NP (JJ transient) (NN transfection) (NNS assays))) (, ,) (NP-SBJ-17 (NP (JJ mutant) (NNS forms)) (PP (IN of) (NP (NN Rev))) (SBAR (-NONE- *ICH*-100))) (VP (VBP have) (VP (VBN been) (VP (VBN identified) (NP (-NONE- *-17)) (SBAR-100 (WHNP-18 (WDT that)) (S (NP-SBJ (-NONE- *T*-18)) (VP-COOD (VP (VBP inhibit) (NP (JJ wild-type) (NN Rev) (NN activity))) (CC and) (RB therefore) (VP (VBP suppress) (NP (JJ viral) (NN replication))))))))) (. .))
(S (S-ADV (NP-SBJ (-NONE- *)) (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (NP-SBJ-19 (JJ such) (JJ transdominant) (NN Rev) (NNS proteins)) (VP (MD could) (VP (VB provide) (NP (NP (JJ long-term) (NN protection)) (PP (IN against) (NP (NN HIV) (NN infection)))) (PP (IN without) (S (NP-SBJ (-NONE- *-19)) (VP (VBG affecting) (NP (NN T) (NN cell) (NN function)))))))))))) (, ,) (NP-SBJ-20 (NN T) (NN leukemia) (NN cell) (NNS lines)) (VP (VBD were) (ADVP (RB stably)) (VP (VBN transduced) (NP (-NONE- *-20)) (PP (IN with) (NP (NP (DT a) (JJ retroviral) (NN vector)) (VP (VBG encoding) (NP (NP (NP (DT a) (JJ transdominant) (NN mutant)) (PP (IN of) (NP (DT the) (NN Rev) (NN protein)))) (, ,) (NP (NN M10)))))))) (. .))
(S (SBAR-ADV (IN While) (S (NP-SBJ (PDT all) (DT the) (JJ M10-expressing) (NN cell) (NNS lines)) (VP (VBD remained) (ADJP-PRD (JJ infectable) (PP (IN by) (NP (NN HIV-1))))))) (, ,) (NP-SBJ-21 (DT these) (JJ same) (NNS cells)) (VP (VBD failed) (S (NP-SBJ-22 (-NONE- *-21)) (VP (TO to) (VP (VB support) (NP (DT a) (JJ productive) (NN replication) (NN cycle)) (SBAR-TMP (WHADVP-24 (WRB when)) (S (NP-SBJ-23 (-NONE- *-22)) (VP (VBN infected) (NP (-NONE- *-23)) (PP (IN with) (NP (NP (DT a) (VBN cloned) (NN isolate)) (PP (IN of) (NP (NN HIV-1))))) (ADVP (-NONE- *T*-24))))))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (QP (CD two) (IN out) (IN of) (CD three)) (JJ M10-expressing) (NN CEM) (NNS clones)) (VP (VBD were) (ADJP-PRD (RB also) (JJ resistant) (PP (TO to) (NP (NP (ADJP (RB highly) (JJ productive)) (NN infection)) (PP (IN by) (NP (DT a) (JJ heterogeneous) (NN HIV-1) (NN pool))))))) (. .))
(S (NP-SBJ (NP (NN Expression)) (PP (IN of) (NP (NN M10)))) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (NN induction)) (PP (IN of) (NP (NN HIV) (NN transcription))) (VP (VBN mediated) (NP (-NONE- *)) (PP (IN by) (NP-LGS-COOD (NP (DT the) (NN kappa) (NN B) (JJ regulatory) (NN element)) (CC or) (NP (NN Tat)))))))) (. .))
(S (ADVP (RB Importantly)) (, ,) (NP-SBJ (NP (JJ constitutive) (NN expression)) (PP (IN of) (NP (NN Rev) (NN M10)))) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (DT the) (NN secretion)) (PP (IN of) (NP (NN interleukin) (CD 2)))) (PP (IN in) (NN response) (TO to) (NP (NP (NN mitogen) (NN stimulation)) (PP (IN of) (NP (NP-COOD (NP (NN EL-4)) (CC and) (NP (NN Jurkat))) (NNS cells))))))) (. .))
(S (NP-SBJ (NP (DT The) (NN inhibition)) (PP (IN of) (NP (NN HIV) (NN infection))) (PP (IN in) (NP (NP (NNS cells)) (VP (ADVP (RB stably)) (VBG expressing) (NP (DT a) (JJ transdominant) (NN Rev) (NN protein))))) (, ,) (PP (IN in) (DT the) (NN absence) (IN of) (NP (NP (DT any) (JJ deleterious) (NN effect)) (PP (IN on) (NP (NN T) (NN cell) (NN function))))) (, ,)) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (PDT such) (DT a) (NN strategy)) (VP (MD could) (VP (VB provide) (NP (DT a) (JJ therapeutic) (NN effect)) (PP (IN in) (NP (NP (DT the) (NN T) (NNS lymphocytes)) (PP (IN of) (NP (VBN acquired) (NN immunodeficiency) (NN syndrome) (NNS patients)))))))))) (. .))
